Cargando…

Efficacy and safety of surfactant administration by MIST and INSURE techniques in Neonates with Respiratory Distress Syndrome: A randomized controlled trial

OBJECTIVE: To measure the efficacy and safety of surfactant administered by MIST and INSURE to neonates with respiratory distress syndrome. METHODS: A randomized controlled trial was conducted from June 2021 to August 2022 at the NICU of the University of Child Health Sciences, Lahore. Neonates meet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaleem, Ammara, Haroon, Farah, Fatima, Bushra, Victor, Gideon, Qadir, Mazhar, Waheed, Khawaja Ahmed Irfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214821/ https://www.ncbi.nlm.nih.gov/pubmed/37250559 http://dx.doi.org/10.12669/pjms.39.3.7283

Ejemplares similares

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

The synergistic antibacterial activity of ozone and surfactant mists
por: Epelle, Emmanuel I., et al.
Publicado: (2023)

The Influence of the Technique of Surfactant Administration (LISA vs INSURE) on the Outcomes of Respiratory Distress Syndrome Treatment in Preterm Infants
por: Kaniewska, Urszula, et al.
Publicado: (2019)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
por: Han, Tongyan, et al.
Publicado: (2020)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

Surfactant lung delivery with LISA and InSurE in adult rabbits with respiratory distress
por: Ricci, Francesca, et al.
Publicado: (2021)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

ADMINISTRATION OF ANTENATAL GLUCOCORTICOIDS AND POSTNATAL SURFACTANT AMELIORATES RESPIRATORY DISTRESS SYNDROME-ASSOCIATED NEONATAL LETHALITY IN ERK3(−/−) PUPS
por: Guaman, Milenka Cuevas, et al.
Publicado: (2014)

Surfactant without Endotracheal Tube Intubation (SurE) versus Intubation-Surfactant-Extubation (InSurE) in Neonatal Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
por: Wang, Lirong, et al.
Publicado: (2022)

Enhanced INSURE (ENSURE): an updated and standardised reference for surfactant administration
por: Fortas, Feriel, et al.
Publicado: (2021)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
por: Tarocco, Anna, et al.
Publicado: (2015)

Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Retracted: Surfactant without Endotracheal Tube Intubation (SurE) versus Intubation-Surfactant-Extubation (InSurE) in Neonatal Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Night of the Mist
por: Colwell, Catherine
Publicado: (1960)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
por: Koh, Ji Won, et al.
Publicado: (2018)

Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art
por: Erdeve, Ömer, et al.
Publicado: (2021)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
por: Tarocco, Anna, et al.
Publicado: (2015)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Surfactant administration in neonates: A review of delivery methods
por: Nouraeyan, Nina, et al.
Publicado: (2014)

Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease —research or clinical application?
por: Greenough, Anne
Publicado: (1995)

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome
por: Stockley, Elizabeth, et al.
Publicado: (2018)

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
por: Logan, J Wells, et al.
Publicado: (2009)

Correlation between surfactant protein B mRNA expression and neonatal respiratory distress syndrome
por: YIN, XIAOJUAN, et al.
Publicado: (2012)

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Miao, Jing, et al.
Publicado: (2020)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

Wing Patterns in the Mist
por: Martin, Arnaud, et al.
Publicado: (2010)

The CERN version of MIST
por: McCarroll, S J
Publicado: (1963)

The Cholera Mist Again
Publicado: (1866)

Dust, Mist and Clouds
Publicado: (1883)

Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome
por: Vitali, Francesca, et al.
Publicado: (2014)

Surfactant Therapy for Neonatal Respiratory Distress Syndrome: A Review of Korean Experiences over 17 Years
por: Bae, Chong-Woo, et al.
Publicado: (2009)

Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates
por: Tsitoura, Maria-Eleni I., et al.
Publicado: (2016)

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome
por: Xiang, Jiajun, et al.
Publicado: (2019)

Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea
por: Shin, Jeong Eun, et al.
Publicado: (2020)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
por: Mikolajcikova, Silvia, et al.
Publicado: (2022)

Diagnostic Challenges in Neonatal Respiratory Distress—Congenital Surfactant Metabolism Dysfunction Caused by ABCA3 Mutation
por: Rogulska, Justyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_moumk6eh368kj1qaid3jmonaam